Maternal Hyperoxygenation for Prenatal Risk Stratification of Pulmonary Venous Obstruction in Total Anomalous Pulmonary Venous Return - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Prenatal Risk Assessment of Pulmonary Venous Obstruction in Total Anomalous Pulmonary Venous Return through Maternal Hyperoxygenation

  • By

  • Michelle Mathevosian

  • Shuo Wang

  • Arpine Davtyan

  • Jon Detterich

  • Jodie Votava-Smith

  • Jay Pruetz

  • September 5, 2026

Share

  • 1

    Total anomalous pulmonary venous return (TAPVR) is a rare congenital heart defect characterized by abnormal pulmonary vein drainage.

  • 2

    Pulmonary venous obstruction (PVO) occurs in 25–50% of TAPVR cases and significantly impacts neonatal morbidity and mortality.

  • 3

    Maternal hyperoxygenation (MHO) enhances fetal pulmonary blood flow and may reveal previously undetected anatomical obstructions.

  • 4

    MHO testing was conducted on three fetuses with TAPVR, correlating Doppler measurements with neonatal clinical outcomes.

  • 5

    Case findings indicated that MHO can provide critical insights for perinatal planning and potential postnatal interventions.

Original Source(s)

Related Content